Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19.

MLA

Aleebrahim-Dehkordi, Elahe, et al. “Targeting the Vital Non-Structural Proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and Inhibition of RNA Polymerase by Natural Bioactive Compound Naringenin as a Promising Drug Candidate against COVID-19.” Journal of Molecular Structure, vol. 1287, Sept. 2023, p. 135642. EBSCOhost, https://doi.org/10.1016/j.molstruc.2023.135642.

APA

Aleebrahim-Dehkordi, E., Ghoshouni, H., Koochaki, P., Esmaili-Dehkordi, M., Aleebrahim, E., Chichagi, F., Jafari, A., Hanaei, S., Heidari-Soureshjani, E., & Rezaei, N. (2023). Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19. Journal of Molecular Structure, 1287, 135642. https://doi.org/10.1016/j.molstruc.2023.135642

Chicago

Aleebrahim-Dehkordi, Elahe, Hamed Ghoshouni, Pooneh Koochaki, Mohsen Esmaili-Dehkordi, Elham Aleebrahim, Fatemeh Chichagi, Ali Jafari, Sara Hanaei, Ehsan Heidari-Soureshjani, and Nima Rezaei. 2023. “Targeting the Vital Non-Structural Proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and Inhibition of RNA Polymerase by Natural Bioactive Compound Naringenin as a Promising Drug Candidate against COVID-19.” Journal of Molecular Structure 1287 (September): 135642. doi:10.1016/j.molstruc.2023.135642.